Brief: ERYTECH Pharma Reports Q1 Net Loss Of EUR 11.9 Million
May 12 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH PHARMA SA - NET LOSS FOR Q1 OF 2022 WAS EUR 11.9
MILLION
Source text for Eikon: ID:nGNX8Vf0DM
Further company coverage: ERYP.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure